Regulators are unsure what to accept as proof that an anti-wasting drug helps. Agreeing on a simple measure such as stair climbing would unblock the whole field.
Cachexia drug development has repeatedly stalled on endpoint uncertainty: weight is easy but not clearly meaningful, and composite quality-of-life measures are noisy. Candidate function measures (stair climb power, six-minute walk, handgrip strength, wearable-derived daily step count) are simple and reproducible but not formally qualified. A qualification programme with pre-competitive data pooling would create a defined path.
Shares Cachexia, toxicity and the limits of the patient, Geriatric assessment, Exercise & lifestyle oncology, Patients lack understanding, navigation and agency.
Shares ROMANA 1 and ROMANA 2, Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine, Cachexia, toxicity and the limits of the patient, Exercise & lifestyle oncology.
Shares Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine, Cachexia, toxicity and the limits of the patient, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Exercise & lifestyle oncology.
Shares Cachexia, toxicity and the limits of the patient, Exercise & lifestyle oncology, Trial design, endpoints and cost.
Shares Cachexia, toxicity and the limits of the patient, Geriatric assessment, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards, Exercise & lifestyle oncology.
Shares ROMANA 1 and ROMANA 2, Cachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine, Geriatric assessment, Supportive care and survivorship roadmap: making treatment bearable → proving it extends life → caring for tens of millions afterwards.
Shares Patients lack understanding, navigation and agency, Trial design, endpoints and cost.
Shares Patients lack understanding, navigation and agency, Trial design, endpoints and cost.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/